We are live on ! Find out more
LIA

LS Investment Advisors Portfolio holdings

AUM $738M
1-Year Est. Return 29.35%
This Fund
S&P 500
This Quarter Est. Return
+4.08%
1 Year Est. Return
+29.35%
3 Year Est. Return
+85.73%
5 Year Est. Return
+98.39%
10 Year Est. Return
+364.74%
AUM
$1.42B
AUM Growth
+$57.8M
Cap. Flow
+$19.3M
Cap. Flow %
1.36%
Top 10 Hldgs %
15.45%
Holding
1,908
New
39
Increased
930
Reduced
201
Closed
31

Top Buys

Rank Stock Value
1
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$2.6M
2
DIS icon
Walt Disney
DIS
+$1.89M
3
GE icon
GE Aerospace
GE
+$1.51M
4
WMT icon
Walmart Inc
WMT
+$1.13M
5
CSCO icon
Cisco
CSCO
+$1.12M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$8.03M
2
VTRS icon
Viatris
VTRS
+$3.39M
3
CTAS icon
Cintas
CTAS
+$1.18M
4
TWX
Time Warner Inc
TWX
+$1.12M
5
RAI
Reynolds American Inc
RAI
+$1.09M

Sector Composition

Rank Sector Weight
1 Financials 16.69%
2 Technology 13.39%
3 Healthcare 12.93%
4 Industrials 11.07%
5 Consumer Discretionary 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIME
976
DELISTED
Time Inc.
TIME
$124K 0.01%
6,942
+267
+4% +$3.96K
AER icon
977
AerCap
AER
$24.2B
$123K 0.01%
2,964
CVSA
978
Covista Inc
CVSA
$4.34B
$123K 0.01%
3,942
+250
+7% +$6.76K
POLY
979
DELISTED
Plantronics, Inc.
POLY
$123K 0.01%
2,246
+155
+7% +$8.11K
CMD
980
DELISTED
Cantel Medical Corporation
CMD
$122K 0.01%
1,544
+9
+0.6% +$699
AKS
981
DELISTED
AK Steel Holding Corp
AKS
$121K 0.01%
11,896
+3,261
+38% +$24.8K
ALE
982
DELISTED
Allete
ALE
$120K 0.01%
1,865
+68
+4% +$4.16K
BMRN icon
983
BioMarin Pharmaceuticals
BMRN
$11.6B
$120K 0.01%
1,451
MKSI icon
984
MKS Inc
MKSI
$20.9B
$120K 0.01%
2,025
+75
+4% +$4.05K
HA
985
DELISTED
Hawaiian Holdings, Inc.
HA
$120K 0.01%
2,103
+77
+4% +$3.93K
NSR
986
DELISTED
Neustar Inc
NSR
$120K 0.01%
3,606
+145
+4% +$3.84K
ALKS icon
987
Alkermes
ALKS
$8.31B
$119K 0.01%
2,146
ATI icon
988
ATI
ATI
$26.4B
$119K 0.01%
7,458
-41
-0.5% -$681
TARO
989
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$119K 0.01%
1,134
TEVA icon
990
Teva Pharmaceuticals
TEVA
$40.2B
$118K 0.01%
3,260
SANM icon
991
Sanmina
SANM
$10.4B
$117K 0.01%
3,184
+103
+3% +$3.26K
TECH icon
992
Bio-Techne
TECH
$11.2B
$117K 0.01%
4,568
+400
+10% +$10.5K
TPH
993
DELISTED
Tri Pointe Homes
TPH
$117K 0.01%
10,151
+677
+7% +$8.09K
UBSI icon
994
United Bankshares
UBSI
$6.7B
$117K 0.01%
2,522
+94
+4% +$3.99K
STL
995
DELISTED
Sterling Bancorp
STL
$117K 0.01%
4,983
+183
+4% +$3.79K
CRS icon
996
Carpenter Technology
CRS
$27B
$115K 0.01%
3,190
+199
+7% +$7.38K
PCH
997
DELISTED
PotlatchDeltic
PCH
$115K 0.01%
2,759
+212
+8% +$8.55K
PNFP icon
998
Pinnacle Financial Partners Inc
PNFP
$16.2B
$115K 0.01%
1,654
+61
+4% +$3.68K
BLKB icon
999
Blackbaud
BLKB
$2.01B
$114K 0.01%
1,783
+87
+5% +$5.57K
CACI icon
1000
CACI
CACI
$11.3B
$114K 0.01%
914
+34
+4% +$3.93K

Similar funds

LS Investment Advisors's Q4 2016 Portfolio in Review

As of Q4 2016, LS Investment Advisors held 1,908 positions worth $1.42B, up 4.2% from $1.36B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Trading was light in Q4 2016: portfolio turnover was 3.7%. LS Investment Advisors opened 39 new positions and exited 31, leaving the 1,908-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • LS Investment Advisors's largest Q4 2016 buy was iShares MSCI USA Value Factor ETF: 38,550 shares worth $2.71M.
  • LS Investment Advisors added most to Walt Disney in Q4 2016, an estimated $1.89M increase.
  • LS Investment Advisors's biggest Q4 2016 reduction was McKesson, cutting an estimated $8.03M.
  • LS Investment Advisors fully exited Alcoa in Q4 2016, selling an estimated $492K.
  • LS Investment Advisors's ten largest holdings make up 15% of its $1.42B portfolio in Q4 2016.
  • LS Investment Advisors opened 39 new positions and closed 31 in Q4 2016.
  • LS Investment Advisors's portfolio value rose 4.2% quarter-over-quarter to $1.42B.

Based on LS Investment Advisors's 13F filing for Q4 2016, filed 9 Feb 2017.